NASDAQ: RTRX $1 Million Small-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 9%. 1 Year Return 83%. 2021 YTD Return 100%. Since Earnings 0%.
The 52 Week Low is $9.45 set on Fri, Apr 3, 2020.
The 52 Week High is $22.55 set on Tue, Jan 21, 2020.
The All-Time High is $0.00 set on Wed, Dec 31, 1969.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Retrophin Inc trades on the NASDAQ. RTRX's market cap is 1.2 Billion.
Retrophin Inc is a biopharmaceutical company. The company is focused on the development and commercialization of innovative therapies for people with serious and life-threatening rare diseases and medical conditions. Its product pipeline includes Chenodal, Cholbam, Thiola, and Thiola EC.
For Starters
Track your portfolio and more.
